Histocompatibility Assessment in Precision Medicine for Transplantation: Towards a Better Match

Human Leukocyte Antigen (HLA) diversity is the key driver of alloimmune responses. Ideally, patients would receive an allograft that is fully matched at the allelic level. However, the extensive polymorphism in the HLA loci renders this impractical. Thus, there is growing interest in determining whether HLA mismatches at the eplet/epitope level better reflects the true disparity between a donor-recipient pair, with the goal of predicting permissible mismatches versus those that should be avoided because they will elicit a strong alloimmune response.

Source: Seminars in Nephrology - January 1, 2022 Category: Urology & Nephrology Authors: Melissa Y. Yeung Source Type: research